Important news…the FDA will be holding a public workshop on Labeling “Lower” Dose Estrogen-Alone Products for Symptoms of Vulvar and Vaginal Atrophy (VVA) on November 10, 2015 that you may be interested in. This workshop will be held on the White ...
Read More »News From NAMS- Continuing Use of Systemic Hormone Therapy After Age 65
The North American Menopause Society Statement on Continuing Use of Systemic Hormone Therapy After Age 65 The 2012 Hormone Therapy Position Statement of The North American Menopause Society (NAMS) states that hormone therapy (HT) is the most effective treatment for ...
Read More »